The Head and Neck Oncology Program (HNOP) is a comprehensive program in head and neck cancer research that includes a multidisciplinary team of Investigators In basic, clinical, behavioral, population and translational research. The program consists of 44 members from 11 departments in five schools across the University of Michigan. The HNOP's direct cost funding has increased by 60% over this grant period, to over $5 million of which $2 is in NCI funding, including a Head and Neck SPORE. Program members published 293 papers during this grant period, 22.5% of which demonstrated intra-programmatic and 33.4% Inter-programmatic collaborations. Many members of this program also hold joint membership in other Cancer Center basic science or prevention programs which integrate additional fundamental research into the underlying mechanisms of head and neck cancer behavior and treatment. The major research themes of the HNOP are to; 1. Identify mechanisms of carcinogenesis and progression 2. Determine the molecular determinants of treatment response 3. Characterize the immunobiology of the tumor microenvironment to better modulate the immune system as a therapeutic modality 4. Characterize the role of cancer stem cells in tumor progression, Invasion, metastasis and resistance to treatment 5. Define new treatment combinations based on laboratory and clinical studies that define new biomarkers for individualized therapies 6. Define organ preservation strategies in head and neck cancer 7. Develop and implement novel reconstruction and rehabilitation techniques for head and neck cancer patients This program has undergone considerable recruitment over this grant period with 18 new faculty members, and a renewed/expanded emphasis on translational research that should become fully realized over the next grant cycle.

Agency
National Institute of Health (NIH)
Type
Center Core Grants (P30)
Project #
5P30CA046592-26
Application #
8696608
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
26
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Lee, Alice W; Ness, Roberta B; Roman, Lynda D et al. (2016) Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol 127:828-36
Mathewson, Nathan D; Jenq, Robert; Mathew, Anna V et al. (2016) Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 17:505-13
Owen, John Henry; Graham, Martin P; Chinn, Steven B et al. (2016) Novel method of cell line establishment utilizing fluorescence-activated cell sorting resulting in 6 new head and neck squamous cell carcinoma lines. Head Neck 38 Suppl 1:E459-67
Peng, Dongjun; Tanikawa, Takashi; Li, Wei et al. (2016) Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. Cancer Res 76:3156-65
Kadakia, Kunal C; Snyder, Claire F; Kidwell, Kelley M et al. (2016) Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer. Oncologist 21:539-46
Boonstra, Philip S; Mukherjee, Bhramar; Gruber, Stephen B et al. (2016) Tests for Gene-Environment Interactions and Joint Effects With Exposure Misclassification. Am J Epidemiol 183:237-47
Amin, Nisar A; Malek, Sami N (2016) Gene mutations in chronic lymphocytic leukemia. Semin Oncol 43:215-21
Hardiman, Karin M; Ulintz, Peter J; Kuick, Rork D et al. (2016) Intra-tumor genetic heterogeneity in rectal cancer. Lab Invest 96:4-15
Boonstra, Philip S; Taylor, Jeremy M G; Smolska-Ciszewska, Beata et al. (2016) Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. Br J Radiol 89:20150957
Di Girolamo, Daniela; Ambrosio, Raffaele; De Stefano, Maria A et al. (2016) Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis. J Clin Invest 126:2308-20

Showing the most recent 10 out of 1165 publications